Sang-Yoon Lee
Chief Executive Officer bij INTEKPLUS CO., LTD.
Vermogen: 24 M $ op 31-03-2024
Profiel
Sang-Yoon Lee is currently the CEO, Director, and Head of Research & Development at INTEKPLUS Co., Ltd.
He is also a Director at Absology Co., Ltd.
and Intekmedi Co. Ltd.
Mr. Lee has an undergraduate and graduate degree from Seoul National University and a graduate degree from Korea Advanced Institute of Science & Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INTEKPLUS CO., LTD.
6.81% | 28-02-2024 | 874 678 ( 6.81% ) | 24 M $ | 31-03-2024 |
Actieve functies van Sang-Yoon Lee
| Bedrijven | Functie | Begin |
|---|---|---|
| INTEKPLUS CO., LTD. | Chief Executive Officer | - |
| Intekmedi Co. Ltd. | Director/Board Member | - |
Absology Co., Ltd.
 Absology Co., Ltd. Medical SpecialtiesHealth Technology Absology Co., Ltd. manufactures in-vitro diagnostic medical devices. The company is based in Anyang-si, South Korea. The South Korean company was founded in 2017. The CEO is Han-Sang Cho. | Director/Board Member | - |
Opleiding van Sang-Yoon Lee
| Seoul National University | Graduate Degree |
| Korea Advanced Institute of Science & Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INTEKPLUS CO., LTD. | Electronic Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Absology Co., Ltd.
Absology Co., Ltd. Medical SpecialtiesHealth Technology Absology Co., Ltd. manufactures in-vitro diagnostic medical devices. The company is based in Anyang-si, South Korea. The South Korean company was founded in 2017. The CEO is Han-Sang Cho. | Health Technology |
| Intekmedi Co. Ltd. |
